Search Results

There are 3495 results for: content related to: Sexual Dysfunction among Male Veterans Returning from Iraq and Afghanistan: Prevalence and Correlates

  1. Profiling Characteristics of Men Who Use Phosphodiesterase Type 5 Inhibitors Based on Obtaining Patterns: Data from the Nationwide Japanese Population

    The Journal of Sexual Medicine

    Volume 9, Issue 6, June 2012, Pages: 1649–1658, Masaki Kimura, Satoru Shimura, Hideyuki Kobayashi, Toshihiro Tai, Yutaka Chikano, Shiro Baba, Munehide Kano and Koichi Nagao

    Version of Record online : 18 APR 2012, DOI: 10.1111/j.1743-6109.2012.02728.x

  2. Continuing Medical Education: 2009 Update on Phosphodiesterase Type 5 Inhibitor Therapy Part 2: Updates on Optimal Utilization for Sexual Concerns and Rare Toxicities in This Class (CME)

    The Journal of Sexual Medicine

    Volume 6, Issue 9, September 2009, Pages: 2352–2364, Alan W. Shindel

    Version of Record online : 26 AUG 2009, DOI: 10.1111/j.1743-6109.2009.01447.x

  3. You have free access to this content
    Acute Nonarteritic Anterior Ischemic Optic Neuropathy and Exposure to Phosphodiesterase Type 5 Inhibitors

    The Journal of Sexual Medicine

    Volume 12, Issue 1, January 2015, Pages: 139–151, Ulka B. Campbell, Alexander M. Walker, Michael Gaffney, Kenneth R. Petronis, Dana Creanga, Sheila Quinn, Barbara E.K. Klein, Alan M. Laties, Michael Lewis, Ira D. Sharlip, Francesca Kolitsopoulos, Brian J. Klee, Jingping Mo and Robert F. Reynolds

    Version of Record online : 31 OCT 2014, DOI: 10.1111/jsm.12726

  4. Recreational Use of Phosphodiesterase Type 5 Inhibitors by Healthy Young Men

    The Journal of Sexual Medicine

    Volume 7, Issue 11, November 2010, Pages: 3736–3742, Amado Bechara, Adolfo Casabé, Walter De Bonis, Adrián Helien and María Victoria Bertolino

    Version of Record online : 16 AUG 2010, DOI: 10.1111/j.1743-6109.2010.01965.x

  5. Continuing Medical Education: 2009 Update on Phosphodiesterase Type 5 Inhibitor Therapy Part 1: Recent Studies on Routine Dosing for Penile Rehabilitation, Lower Urinary Tract Symptoms, and Other Indications (CME)

    The Journal of Sexual Medicine

    Volume 6, Issue 7, July 2009, Pages: 1794–1808, Alan W. Shindel

    Version of Record online : 24 JUN 2009, DOI: 10.1111/j.1743-6109.2009.01347.x

  6. Serum testosterone, testosterone replacement therapy and all-cause mortality in men with type 2 diabetes: retrospective consideration of the impact of PDE5 inhibitors and statins

    International Journal of Clinical Practice

    Volume 70, Issue 3, March 2016, Pages: 244–253, G. Hackett, A. H. Heald, A. Sinclair, P. W. Jones, R. C. Strange and S. Ramachandran

    Version of Record online : 24 FEB 2016, DOI: 10.1111/ijcp.12779

  7. The Controversial Role of Phosphodiesterase Type 5 Inhibitors in the Treatment of Premature Ejaculation

    The Journal of Sexual Medicine

    Volume 8, Issue 8, August 2011, Pages: 2135–2143, Emmanuele A. Jannini, Chris McMahon, Juza Chen, Antonio Aversa and Michael Perelman

    Version of Record online : 26 JUL 2011, DOI: 10.1111/j.1743-6109.2011.02401.x

  8. You have free access to this content
    Prospective analysis of penile length changes after radical prostatectomy

    BJU International

    Volume 113, Issue 5b, May 2014, Pages: E131–E136, Boback M. Berookhim, Christian J. Nelson, Brian Kunzel, John P. Mulhall and Joseph B. Narus

    Version of Record online : 2 DEC 2013, DOI: 10.1111/bju.12443

  9. You have free access to this content
    Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study

    International Journal of Clinical Practice

    Volume 65, Issue 7, July 2011, Pages: 797–806, M. G. Kirby, G. Schnetzler, K.H. Zou and T. Symonds

    Version of Record online : 16 JUN 2011, DOI: 10.1111/j.1742-1241.2011.02693.x

  10. You have free access to this content
    PDE5 inhibitors: considerations for preference and long-term adherence

    International Journal of Clinical Practice

    Volume 67, Issue 8, August 2013, Pages: 768–780, W. B. Smith II, I. R. McCaslin, A. Gokce, S. H. Mandava, L. Trost and W. J. Hellstrom

    Version of Record online : 22 JUL 2013, DOI: 10.1111/ijcp.12074

  11. ORIGINAL RESEARCH–ED PHARMACOTHERAPY: Do Phosphodiesterase Type 5 Inhibitors Protect Against Condom-Associated Erection Loss and Condom Slippage?

    The Journal of Sexual Medicine

    Volume 6, Issue 5, May 2009, Pages: 1451–1456, Stephanie A. Sanders, Robin R. Milhausen, Richard A. Crosby, Cynthia A. Graham and William L. Yarber

    Version of Record online : 27 APR 2009, DOI: 10.1111/j.1743-6109.2009.01267.x

  12. Proceedings of the 19th Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, New Orleans, USA, November 21–24 2013

    The Journal of Sexual Medicine

    Volume 11, Issue S3, April 2014, Pages: 138–204,

    Version of Record online : 14 APR 2014, DOI: 10.1111/jsm.12528

  13. ORIGINAL RESEARCH—ED PHARMACOTHERAPY: Characteristics, Behaviors, and Attitudes of Men Bypassing the Healthcare System When Obtaining Phosphodiesterase Type 5 Inhibitors

    The Journal of Sexual Medicine

    Volume 7, Issue 3, March 2010, Pages: 1237–1246, Gabriel Schnetzler, Ian Banks, Mike Kirby, Kelly H. Zou and Tara Symonds

    Version of Record online : 2 FEB 2010, DOI: 10.1111/j.1743-6109.2009.01674.x

  14. Systematic review and meta-analysis of phosphodiesterase type 5 inhibitors for the treatment of female sexual dysfunction

    International Journal of Gynecology & Obstetrics

    Volume 133, Issue 2, May 2016, Pages: 139–145, Liang Gao, Lu Yang, Shengqiang Qian, Tao Li, Ping Han and Jiuhong Yuan

    Version of Record online : 17 DEC 2015, DOI: 10.1016/j.ijgo.2015.08.015

  15. Phosphodiesterase Type 5 Inhibitors Facilitate Noncontact Erections in Male Rats: Site of Action in the Brain and Mechanism of Action

    The Journal of Sexual Medicine

    Volume 6, Issue 10, October 2009, Pages: 2680–2689, Fabrizio Sanna, Salvatora Succu, Antonio Boi, Maria Rosaria Melis and Antonio Argiolas

    Version of Record online : 12 AUG 2009, DOI: 10.1111/j.1743-6109.2009.01410.x

  16. Toward Personalized Sexual Medicine (Part 2): Testosterone Combined with a PDE5 Inhibitor Increases Sexual Satisfaction in Women with HSDD and FSAD, and a Low Sensitive System for Sexual Cues

    The Journal of Sexual Medicine

    Volume 10, Issue 3, March 2013, Pages: 810–823, Saskia Poels, Jos Bloemers, Kim van Rooij, Irwin Goldstein, Jeroen Gerritsen, Diana van Ham, Frederiek van Mameren, Meredith Chivers, Walter Everaerd, Hans Koppeschaar, Berend Olivier and Adriaan Tuiten

    Version of Record online : 6 NOV 2012, DOI: 10.1111/j.1743-6109.2012.02983.x

  17. Combination of Vacuum Erection Device and PDE5 Inhibitors as Salvage Therapy in PDE5 Inhibitor Nonresponders with Erectile Dysfunction

    The Journal of Sexual Medicine

    Volume 6, Issue 9, September 2009, Pages: 2561–2567, Onder Canguven, James Bailen, William Fredriksson, David Bock and Arthur L. Burnett

    Version of Record online : 16 JUL 2009, DOI: 10.1111/j.1743-6109.2009.01364.x

  18. Physical Activity and PDE5 Inhibitors in the Treatment of Erectile Dysfunction: Results of a Randomized Controlled Study

    The Journal of Sexual Medicine

    Volume 7, Issue 6, June 2010, Pages: 2201–2208, Giuseppe Maio, Salim Saraeb and Antonio Marchiori

    Version of Record online : 30 MAR 2010, DOI: 10.1111/j.1743-6109.2010.01783.x

  19. Interventions for treating sexual dysfunction in patients with chronic kidney disease

    Intervention Review

    The Cochrane Library

    Mariacristina Vecchio, Sankar D Navaneethan, David W Johnson, Giuseppe Lucisano, Giusi Graziano, Valeria Saglimbene, Marinella Ruospo, Marialuisa Querques, Emmanuele A Jannini and Giovanni FM Strippoli

    Published Online : 8 DEC 2010, DOI: 10.1002/14651858.CD007747.pub2

  20. You have free access to this content
    Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy

    BJU International

    Volume 110, Issue 11c, December 2012, Pages: E931–E938, Masaki Kimura, Jorge R. Caso, Lionel L. Bañez, Bridget F. Koontz, Leah Gerber, Cagri Senocak, Craig F. Donatucci, Zeljko Vujaskovic, Judd W. Moul and Thomas J. Polascik

    Version of Record online : 23 APR 2012, DOI: 10.1111/j.1464-410X.2012.11168.x